DaVita Venture Group - aVenture Asset Manager Research
Location
Denver, CO, US
Founded
2019
DaVita Venture Group focuses on healthcare innovations, particularly in the realm of kidney disease and related conditions. The firm invests in early-stage companies, typically participating in Seed and Series A rounds. Their investment strategy aims to improve patient outcomes and transform the future of healthcare for individuals with chronic diseases.
Notable portfolio companies include Dock Health, Nephrosant, Pathalys Pharma, and Wellth. DaVita Venture Group builds partnerships with healthcare innovators, leveraging their expertise in the kidney care space to support and guide their portfolio companies. The firm's commitment to improving patient lives drives their investment decisions and collaborative approach with founding teams.
DaVita Venture Group - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
